Tag Archives: Genetics

Thursday, August 15th 2019 at 2:27pm UTC DUBLIN–(BUSINESS WIRE)– The « In situ Hybridization – Market Analysis, Trends, and Forecasts » report has been added to ResearchAndMarkets.com’s offering. In situ Hybridization market worldwide is projected to grow by US$282.5 Thousand, guided by a compounded growth of 5.6%. Staying on top of trends …

Wednesday, August 14th 2019 at 12:00pm UTC SAN JOSE, Calif.–(BUSINESS WIRE)– Accellix Inc. announces the appointment of a new Board Member, Mr. Charles Piazza. Charles (Chuck) Piazza, Accellix’s newest board member, has over 35 years of global experience within the life science industry serving the pharmaceutical, biotechnology and medical research …

Thursday, August 15th 2019 at 8:10pm UTC – First FDA-approved treatment designed to target both ROS1 and NTRK that also shows response in cancer that has spread to the brain – – Genentech’s first FDA-approved tumor-agnostic medicine – SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– Genentech, a member of the Roche Group …

Thursday, August 15th 2019 at 4:00pm UTC On the West Coast, City of Hope is the first institution to open the Kite-sponsored trial DUARTE, Calif.–(BUSINESS WIRE)– The first-in-human, phase 1 T cell trial for patients who have human papillomavirus (HPV)-associated cancers that have relapsed, or are resistant to treatment, is …

Thursday, August 15th 2019 at 4:16pm UTC Combined company uniquely suited to drive precision oncology forward with RNA technologies to identify oncology drug responder populations DURHAM, N.C.–(BUSINESS WIRE)– GeneCentric Therapeutics, Inc. today announced that it has acquired Select ImmunoGenomics, LLC, a Chapel Hill, NC-based provider of advanced immunogenomic, data analysis …

Thursday, August 15th 2019 at 12:00pm UTC CTD presentation to take place at the National Niemann-Pick Disease Foundation Conference August 16, 2019 ALACHUA, Fla.–(BUSINESS WIRE)– CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin-based products for the treatment of disease with unmet medical need, today posted …

Wednesday, August 14th 2019 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, announced today that the Company and its collaborators will present at the 2019 International Congress on Porphyrins and Porphyria (ICPP), being held September 8-11, 2019 in Milan, Italy. Presentations will …

Monday, August 19th 2019 at 12:05pm UTC – Unique collaborative service combines innovative digital health platform and genetic testing to improve patient wellness and lower costs across the continuum of care for conditions including depression, anxiety, PTSD, and substance abuse – Software applications empower patient engagement and integrate synergistically with …

Friday, August 16th 2019 at 12:30pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– AVROBIO, Inc. (NASDAQ: AVRO) (“AVROBIO” or the “Company”), a Phase 2 clinical-stage gene therapy company, today announced the appointment of Georgette Verdin as Chief Human Resources Officer (CHRO). Ms. Verdin will be responsible for all aspects of human resources, including …

Monday, August 19th 2019 at 12:00pm UTC CAMBRIDGE, Mass.–(BUSINESS WIRE)– Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced the appointment of Lawrence Klein, Ph.D., to its Board of Directors. “Dyne’s FORCE therapeutic platform achieves a unique combination of tissue-specific delivery, high potency …